Equal safety of rivaroxaban and vitamin K antagonists with regard to the risk of intracranial- and gastrointestinal bleeding in patients with venous thromboembolism - A Danish nationwide study

被引：0
|
作者：
Sindet-Pedersen, C. [1 ]
Pallisgaard, J. Langtved [1 ]
Gislason, G. Hilmar [1 ]
Staerk, L. [1 ]
Fosboel, E. Loldrup [2 ]
Torp-Pedersen, C. [3 ]
Olesen, J. Bjerring [1 ]
机构：
[1] Copenhagen Univ Hosp, Gentofte Hosp, Cardiol, Hellerup, Denmark
[2] Copenhagen Univ Hosp, Rigshosp, Dept Cardiol, Copenhagen, Denmark
[3] Aalborg Univ, Inst Hlth Sci & Technol, Aalborg, Denmark
来源：
EUROPEAN HEART JOURNAL | 2016年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5963
引用
收藏
页码：1221 / 1222
页数：2
相关论文
共 50 条
  • [41] Comparison of the Short-Term Risk of Bleeding and Arterial Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Newly Treated With Dabigatran or Rivaroxaban Versus Vitamin K Antagonists A French Nationwide Propensity-Matched Cohort Study
    Maura, Geric
    Blotiere, Pierre-Olivier
    Bouillon, Kim
    Billionnet, Cecile
    Ricordeau, Philippe
    Alla, Francois
    Zureik, Mahmoud
    CIRCULATION, 2015, 132 (13) : 1252 - 1260
  • [42] Clinical impact and course of major bleeding events in patients with venous thromboembolism, treated with factor Xa inhibitors or vitamin K antagonists: an individual patient data analysis
    Brekelmans, M. P. A.
    Bleker, S. M.
    Eerenberg, E. S.
    Cohen, A. T.
    Middeldorp, S.
    Raskob, G.
    Buller, H. R.
    EUROPEAN HEART JOURNAL, 2016, 37 : 394 - 394
  • [43] Bleeding Risk Associated With Non-Steroidal Anti-Inflammatory Drug Use in Patients with Venous Thromboembolism: A Nationwide Cohort Study
    Petersen, Soren Riis
    Bonnesen, Kasper
    Pedersen, Lars
    Grove, Erik Lerkevang
    Schmidt, Morten
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 76 - 76
  • [44] The predictive ability of bleeding risk stratification models in very old patients on vitamin K antagonist treatment for venous thromboembolism: results of the prospective collaborative EPICA study: reply
    Poli, D.
    Antonucci, E.
    Testa, S.
    Cosmi, B.
    Palareti, G.
    Ageno, W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (03) : 423 - 424
  • [45] The predictive ability of bleeding risk stratification models in very old patients on vitamin K antagonist treatment for venous thromboembolism: results of the prospective collaborative EPICA study: comment
    Gaboreau, Y.
    Lebelhomme, A.
    Soave, C.
    Imbert, P.
    Couturier, P.
    Bosson, J. L.
    Pernod, G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (03) : 421 - 423
  • [46] Activated protein C resistance in patients following venous thromboembolism receiving rivaroxaban versus vitamin K antagonists: assessment using Russell viper venom time-based assay
    Goralczyk, Tadeusz
    Wojtowicz, Katarzyna B.
    Undas, Anetta
    BLOOD COAGULATION & FIBRINOLYSIS, 2017, 28 (04) : 309 - 315
  • [47] Benefit-risk of rivaroxaban 20 or 15 mg compared with vitamin-K antagonists in patients with non-valvular atrial fibrillation: A cohort study in the French Nationwide Claims Database
    Blin, Patrick
    Dureau-Pournin, Caroline
    Bernard, Marie-Agnes
    Lassalle, Regis
    Fauchier, Laurent
    Sacher, Frederic
    Dallongeville, Jean
    Droz-Perroteau, Cecile
    Moore, Nicholas
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 34 - 35
  • [48] Risk of dentoalveolar surgery postoperative bleeding in patients taking direct oral anticoagulants and vitamin K antagonists: A prospective observational study
    Bajkin, Branislav, V
    Tadic, Ana J.
    Komsic, Jelena J.
    Vuckovic, Biljana A.
    JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, 2024, 52 (06) : 772 - 777
  • [49] Comparison between characteristics of patients with venous thromboembolism treated with direct oral anticoagulants versus vitamin K antagonists: A single-center prospective study
    Demelo-Rodriguez, Pablo
    Galeano-Valle, Francisco
    Toro-Cervera, Jorge del
    MEDICINA CLINICA, 2020, 155 (03): : 131 - 132
  • [50] Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data
    Sorensen, Rikke
    Hansen, Morten L.
    Abildstrom, Steen Z.
    Hvelplund, Anders
    Andersson, Charlotte
    Jorgensen, Casper
    Madsen, Jan K.
    Hansen, Peter R.
    Kober, Lars
    Torp-Pedersen, Christian
    Gislason, Gunnar H.
    LANCET, 2009, 374 (9706): : 1967 - 1974
12345